Quality assessment of large language model-generated prior authorization letters in nephrology

肾脏病学中基于大型语言模型生成的预先授权函的质量评估

阅读:2

Abstract

BACKGROUND: Prior authorization (PA) is a major source of administrative burden, treatment delay, and clinician burnout. Artificial intelligence (AI), particularly large language models (LLMs), is increasingly used to assist with clinical documentation, yet its reliability for payer-facing administrative tasks remains uncertain. OBJECTIVE: To evaluate the quality of PA letters drafted by ChatGPT-5 for commonly used medications requiring PA in nephrology. Quality was evaluated based on correctness and strength of clinical reasoning. METHODS: We created a single standardized prompt and applied it across 29 nephrology scenarios to generate PA letters. Each PA letter was reviewed against four criteria: 1) absence of false statements or hallucinations, 2) correctness of ICD-10 coding, 3) presence and validity of citations, and 4) clinical reasoning, rated on a 4-point Likert scale (illogical, weak, adequate and strong). FDA drug labels, KDIGO guidelines and related randomized controlled trials were used as reference standards. RESULTS: Out of 29 letters, one letter (3.5%) contained false statements mentioning an irrelevant clinical trial. The ICD-10 diagnosis code was correct in 23 letters (79.3%), most errors were related to chronic kidney disease (CKD) staging or internal diagnostic inconsistencies. 27 letters (93.1%) cited valid references, with one letter citing an incorrect trial and another one citing a correct KDIGO guideline with inaccessible link. Twenty-six letters (89.7%) demonstrated strong clinical reasoning, supported by guideline-oriented or FDA label-aligned justification. The remaining 3 letters were rated as adequate reasoning. The main areas for improvement involved citing relevant references and emphasizing special considerations, for example Risk Evaluation and Mitigation Strategy (REMS) compliance for eculizumab. CONCLUSIONS: ChatGPT-5 can generate clinically coherent PA drafts for nephrology medications, but limitations in coding precision and citation reliability persist. With appropriate oversight, AI-assisted documentation may reduce administrative burden while maintaining safety and accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。